CopyMark Law Group
4.9/5
Drawing for RAPID

USPTO serial 88625032

RAPID

Reviewed by CopyMark Law Group

Reg. 6111599Status 702Renewal
Filing date
Status date
Registration date
Jul 28, 2020
Examiner
FALK, ERIN
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with RAPID?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ned T. Himmelrich

Ned T. Himmelrich GORDON FEINBLATT LLC1001 Fleet StreetSuite 700BALTIMORE, MD 21202

Goods and services

ClassDescriptionStatusFirst use
042Software as a service (SAAS) services featuring software tools for image analysis, [ risk analysis, ] quantitative reconstruction, dosimetry, and prediction of organ toxicity and therapeutic efficacy in the field of radiopharmaceutical therapy for use by medical and research laboratories; provide consulting services to developers of radiopharmaceuticals related to dosimetry, [ risk analysis, ] quantitative reconstruction and dosimetryACTIVESep 20, 2019
044Medical dosimetry services in the field of radiopharmaceutical therapy for treating cancer, hyperthyroidism, or other metabolic or physiological conditions or diseases; medical dosimetry services for diagnostic radiopharmaceuticals for diagnosis or prognosis of metabolic, functional, or physiological conditions or diseases such as neoplasia or neurological, skeletal, respiratory, digestive, cardiovascular, endocrine, reproductive disordersACTIVESep 20, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Sep 30, 2026NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Sep 30, 2026C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Sep 30, 2026COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Sep 21, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 21, 2026E815TEAS SECTION 8 & 15 RECEIVED—
Jul 21, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jul 28, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 12, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 12, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 1, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 4, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 4, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 4, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 2, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 2, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 23, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 23, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2019DOCKASSIGNED TO EXAMINER—
Sep 27, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 26, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance